Eli Lilly & Co (LLY) Stock Statistics & Valuation Metrics

Eli Lilly & Co has a market cap or net worth of CHF 1.12T. The enterprise value is CHF 1.08T.

Market Cap

CHF 1.12T

Enterprise Value

CHF 1.08T

Eli Lilly & Co has 940,745,060 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding

940,745,060

Owned by Insiders

9.92%

Owned by Institutions

56.42%

Eli Lilly & Co’s return on equity (ROE) is 0.78 and return on invested capital (ROIC) is 30.20%.

Return on Equity (ROE)

0.78

Return on Assets (ROA)

0.18

Return on Invested Capital (ROIC)

30.20%

Return on Capital Employed (ROCE)

0.38

Revenue Per Employee

1.30M

Profits Per Employee

412.80K

Employee Count

50,000

Asset Turnover

0.58

Inventory Turnover

0.80

The current PE Ratio of Eli Lilly & Co is 46.54. Eli Lilly & Co’s PEG ratio is 0.92.

PE Ratio

46.54

PS Ratio

15.64

PB Ratio

31.84

Price to FCF

68.79

Price to Operating Cash Flow

41.85

PEG Ratio

0.92

In the last 12 months, Eli Lilly & Co had revenue of 65.18B and earned 20.64B in profits. Earnings per share was 23.07.

Revenue

65.18B

Gross Profit

54.13B

Operating Income

29.70B

Pretax Income

25.73B

Net Income

20.64B

EBITDA

31.69B

Earnings Per Share (EPS)

23.07

In the last 12 months, operating cash flow was 30.64B and capital expenditures -10.98B, giving a free cash flow of 19.66B billion.

Operating Cash Flow

30.64B

Free Cash Flow

19.66B

Free Cash Flow per Share

22.04

Eli Lilly & Co pays an annual dividend of CHF 1.42, resulting in a dividend yield of 0.45%

Dividend Per Share

CHF 1.42

Dividend Yield

0.45%

Payout Ratio

20.99%

Free Cash Flow Yield

1.45%

Earnings Yield

2.15%

Beta

0.64

52-Week Price Change

55.26%

50-Day Moving Average

1003.80

200-Day Moving Average

883.76

Relative Strength Index (RSI)

68.07

Average Volume (3m)

6

Eli Lilly & Co upcoming earnings date is Feb 10, 2027, TBA (Not Confirmed).

Last Earnings Date

Oct 29, 2026

Next Earnings Date

Feb 10, 2027

Ex-Dividend Date

Aug 14, 2026

Eli Lilly & Co as a current ratio of 1.58, with Debt / Equity ratio of 160.18%

Current Ratio

1.58

Quick Ratio

1.19

Debt to Market Cap

0.04

Net Debt to EBITDA

1.12

Interest Coverage Ratio

37.34

In the past 12 months, Eli Lilly & Co has paid 5.09B in taxes.

Income Tax

5.09B

Effective Tax Rate

0.20

Eli Lilly & Co EV to EBITDA ratio is 31.22, with an EV/FCF ratio of 71.06.

EV to Sales

16.16

EV to EBITDA

31.22

EV to Free Cash Flow

71.06

EV to Operating Cash Flow

45.59

Eli Lilly & Co has CHF 4.88B in cash and marketable securities with CHF 49.50B in debt, giving a net cash position of -CHF 44.62B billion.

Cash & Marketable Securities

CHF 4.88B

Total Debt

CHF 49.50B

Net Cash

-CHF 44.62B

Net Cash Per Share

-CHF 47.43

Tangible Book Value Per Share

CHF 13.81

Gross margin is 83.63%, with operating margin of 46.07%, and net profit margin of 31.90%.

Gross Margin

83.63%

Operating Margin

46.07%

Pretax Margin

40.21%

Net Profit Margin

31.90%

EBITDA Margin

51.76%

EBIT Margin

49.24%

The average price target for Eli Lilly & Co is CHF 1,241.92, which is 11.43% higher than the current price. The consensus rating is Strong Buy

Price Target

CHF 1,241.92

Price Target Upside

5.25% Upside

Analyst Consensus

Strong Buy

Analyst Count

24

Revenue Growth Forecast

37.09%

EPS Growth Forecast

42.35%

Smart Score

10

AI Score

―